ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2015

Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability.

Shinya Nishio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.